Apex Biotechnology Market Cap

Apex Biotechnology has a market cap or net worth of 2.87 billion as of April 29, 2026. Its market cap has decreased by -16.20% in one year.

Market Cap

2.87B

Enterprise Value

2.33B

Revenue

1.94B

Ranking

n/a

PE Ratio

17.72

Stock Price

28.70

Market Cap Chart

Since September 7, 2001, Apex Biotechnology's market cap has increased from 1.43B to 2.87B, an increase of 101.30%. That is a compound annual growth rate of 2.88%.

Market Cap History

Date	Market Cap	% Change
Apr 29, 2026	2.87B	-5.75%
Dec 31, 2025	3.04B	1.16%
Dec 31, 2024	3.01B	-25.31%
Dec 29, 2023	4.03B	57.73%
Dec 30, 2022	2.55B	-1.73%
Dec 30, 2021	2.60B	10.38%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
TWi Biotechnology	2.84B
HeXun Biosciences	2.97B
3D Global Biotech	2.76B
Syngen Biotech	2.71B
BRIM Biotechnology	3.06B
SYN-TECH Chem. & Pharm.	3.16B
Genovate Biotechnology	3.19B
Intech Biopharm	3.23B

Market Cap Rankings